Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol

MLA

Chen Chen, et al. “Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent in Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol.” Frontiers in Physiology, vol. 12, Feb. 2022. EBSCOhost, https://doi.org/10.3389/fphys.2021.744968.

APA

Chen Chen, Sha Yu, Weina Yu, Zhiguang Yan, Wei Jin, Jiqiang Si, Menghui Li, Renfei Cai, Dongying Li, Li Wang, Qiuju Chen, Yanping Kuang, Qifeng Lyu, & Hui Long. (2022). Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol. Frontiers in Physiology, 12. https://doi.org/10.3389/fphys.2021.744968

Chicago

Chen Chen, Sha Yu, Weina Yu, Zhiguang Yan, Wei Jin, Jiqiang Si, Menghui Li, et al. 2022. “Luteinizing Hormone Suppression by Progestin-Primed Ovarian Stimulation Is Associated With Higher Implantation Rate for Patients With Polycystic Ovary Syndrome Who Underwent in Vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: Comparing With Short Protocol.” Frontiers in Physiology 12 (February). doi:10.3389/fphys.2021.744968.